Neoadjuvant GW572016 to Treat Breast Cancer

NCT00206427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: GW572016
DRUG: lapatinib

Sponsor

Baylor Breast Care Center

Collaborators

[object Object]